Cigna Group $CI Shares Acquired by Cibc World Market Inc.

Cibc World Market Inc. grew its holdings in Cigna Group (NYSE:CIFree Report) by 58.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,320 shares of the health services provider’s stock after purchasing an additional 14,169 shares during the period. Cibc World Market Inc.’s holdings in Cigna Group were worth $10,547,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of CI. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group in the 4th quarter valued at $28,000. Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group in the 4th quarter valued at $32,000. Collier Financial acquired a new position in shares of Cigna Group in the 3rd quarter valued at $34,000. Creative Financial Designs Inc. ADV lifted its stake in shares of Cigna Group by 147.3% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares during the last quarter. Finally, Activest Wealth Management lifted its stake in shares of Cigna Group by 1,050.0% in the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 3.4%

Shares of NYSE CI opened at $290.17 on Friday. The business’s fifty day simple moving average is $279.58 and its 200-day simple moving average is $277.24. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The stock has a market cap of $76.76 billion, a P/E ratio of 12.30, a PEG ratio of 1.12 and a beta of 0.28.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Analysts Set New Price Targets

Several research firms recently issued reports on CI. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Guggenheim increased their target price on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Morgan Stanley increased their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Finally, Robert W. Baird set a $337.00 target price on Cigna Group in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $338.30.

Read Our Latest Stock Analysis on CI

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.